Journal profile · Gastroenterology & Hepatology
Gastric Cancer
ISSN 1436-3291 · eISSN 1436-3305 · Springer Singapore · JAPAN · Quarterly · Founded 1998
Gastric Cancer: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6; hybrid open access; APC about USD 3,590; median 94 days to acceptance (94 articles, last 24 months); 119 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Gastric Cancer is published by Springer Singapore and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Helicobacter pylori-related gastroenterology studies and Gastrointestinal Tumor Research and Treatment, together about 56% of its articles. Its main subfields are Surgery and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and technical notes, which will be peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning gastric cancer are also welcomed. Review articles are in principle solicited by the Editor. Meeting reports will include summaries of symposia or consensus achieved in the congresses of related associations.
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editor-in-chief Yasuhiro KoderaPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named Japan 33, Italy 2, Mainland China 1, United Kingdom 1, South Korea 1 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine32.4%
- Helicobacter pylori-related gastroenterology studiesMedicine13.6%
- Gastrointestinal Tumor Research and TreatmentMedicine10%
- Esophageal Cancer Research and TreatmentMedicine8.8%
- Metastasis and carcinoma case studiesMedicine5.9%
- Colorectal Cancer Treatments and StudiesMedicine2.6%
- Bariatric Surgery and OutcomesMedicine2.1%
- Esophageal and GI PathologyMedicine2.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6LetPub ·
- Impact factor (publisher) 2025
- 6.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 7.4Publisher website ·
- CiteScore 2026-06
- 11.8LetPub ·
- SJR 2026-06
- 2.49LetPub ·
- SNIP 2026-06
- 2.45LetPub ·
- h-index
- 68LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 1,665OpenAlex ·
- 2-year mean citedness
- 6.15OpenAlex ·
- Self-citation rate
- 1.6%LetPub ·
- Share of gold OA articles
- 43%LetPub ·
Volume
- Articles per year
- 106LetPub ·
- Downloads per year (publisher) 2025
- 1,500,000Publisher website ·
Articles by year OpenAlex count · 2,587 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 102 | 45 | 121 |
| 2025 | 119 | 50 | 433 |
| 2024 | 123 | 120 | 1,562 |
| 2023 | 94 | 91 | 1,238 |
| 2022 | 88 | 88 | 2,890 |
| 2021 | 125 | 121 | 3,945 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 60 days – 124 days
- Acceptance to online
- median 20 days (94 articles)
- Submission to online
- median 112 days
- Sample
- 94 articles with submission and acceptance dates (246 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,590 / EUR 5,490 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Optional
- Not considered
- meta-analysis based on tabulated data
Article types accepted12, with length limits
- case reportGastric Cancer publishes case reports with new findings. The following will be considered for publication. (A) Cases that have an important clinical impact: 1) …main text ≤ 150 words · abstract ≤ 150 words
- case reportsCase reports (up to 1500, excluding references, with no more than seven figures/tables in total)Length not stated
- letters to the editorLetters to the Editor (up to 500 words, excluding references, with no figure/table) should comment on articles published in the journal or expressing views on t…Length not stated
- meeting reportsMeeting reports, at the request of the Editor, will include summaries of symposia or consensus achieved in the congresses of related associations.Length not stated
- original articlet studies related to stomach neoplasms. Original articles (up to 4000 words, excluding references, with no more than seven figures/tablmain text ≤ 4,000 words
- original articlesOriginal articles (up to 4000 words, excluding references, with no more than seven figures/tables in total)Length not stated
- review articleriginality and high scientific quality. Review articles (up to 5000 words, excluding references, with no more than seven figures/tablmain text ≤ 5,000 words
- review articlesReview articles (up to 5000 words, excluding references, with no more than seven figures/tables in total) are in principle solicited by the Editor, but unsolici…Length not stated
- short communicationre than seven figures/tables in total), Short communications (up to 1500 words, excluding references, with no more than four figures/tablemain text ≤ 1,500 words
- short communicationsShort communications (up to 1500 words, excluding references, with no more than four figures/tables in total)Length not stated
- technical notethan four figures/tables in total), and Technical notes (up to 1500 words, excluding references, with no more than seven figures/tablmain text ≤ 1,500 words
- technical notesTechnical notes (up to 1500 words, excluding references, with no more than seven figures/tables in total)Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- Authorship Authorship principles
Only one corresponding author and one last author permitted. Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosure of potential conflicts of interest
Authors must disclose all relationships or interests that could have direct or potential influence or impart bias on the work. Although an author may not feel there is any conflict, disclosure of relationships and interests provides a more complete and transparent process, leading to an accurate and objective assessment of the work. Awareness of a real or perceived conflicts of interest is a persp…
Source ↗Publisher website ·- Publication ethics Ethical Standards
Adopts ICMJE Uniform Requirements for Manuscripts; requires human rights/informed consent statements and animal care statements. Model summary
Gastric Cancer has adopted the Uniform Requirements for Manuscripts (URM) established by the International Committee of Medical Journal Editors (http://www.icmje.org/). The editors reserve the right to reject manuscripts that do not comply with the below-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the below-mentioned requirements. Human ri…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Gastric Cancer, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Member of COPE and follows COPE guidelines on misconduct. Model summary
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
Clinical trial registration required for prospective, randomized, controlled trials with enrollment on or after January 1, 2014; registration recommended prior to enrollment, with 6 months allowed from first patient enrollment. Model summary
Any clinical trial for which patient enrollment began on or after January 1, 2014 must be registered. Authors have 6 months from the first patient enrollment to register the trial, but Gastric Cancer recommends registration prior to enrollment. This registration policy applies to prospective, randomized, controlled trials only. Gastric Cancer follows the International Committee of Medical Journal …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Singapore
- Country or region
- JAPAN
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1436-3291
- Electronic ISSN
- 1436-3305
- Latest issue on the website
- Volume 29, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Gastric Cancer
What CAS zone is Gastric Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Gastric Cancer is in Zone 2 of Medicine, and in Zone 2 of the minor category Gastroenterology & Hepatology / Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Gastric Cancer?
The latest impact factor listed by LetPub is 6; CiteScore 11.8, h-index 128.
How long does peer review take at Gastric Cancer?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 60–124 days); authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Gastric Cancer?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Gastric Cancer based?
Of the 43 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Japan (33), Italy (2) and Mainland China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Gastric Cancer?
According to LetPub and DOAJ records, Gastric Cancer is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Gastric Cancer open access, and what is the APC?
Gastric Cancer is a hybrid journal. For open-access publication: APC about USD 3,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .